搜尋結果
CVS Caremark’s Policy Shift On Humira Biosimilars May Not Be What The Doctor Ordered
Forbes· 3 日前As of March, the blockbuster autoimmune drug Humira (adalimumab) still held 96% of the market ...
Tech Start-Up TAZAAR Prepares For EU’s New Digital Product Passports
Forbes· 2 日前Coming into force in 2026, the DPPs are designed to prioritize a product’s traceability and ...
Exclusive | As Beijing’s ‘Made in China 2025’ plan nears finish line, how well has it done?
South China Morning Post· 6 日前Back then, China stood at the lower end of the global industrial value chain, producing mostly ...
Tottenham 2024-25 kit: New home, away, third & goalkeeper jerseys, release dates, shirt leaks & ...
Goal.com· 2 日前Everything you need to know about the new Tottenham Hotspur kits for the 2024-25 season. The ...
One Burning Question For Every 2nd Round Series Of The NBA Playoffs
Forbes· 1 日前Each playoff series comes down to one defining theme. How do the Timberwolves guard Nikola ...
Global mobility tech company expands engineering talent in China
China Daily· 2 小時前Marelli Holdings Co Ltd, a global mobility technology company, will soon expand its engineering team in China from 800 to ...
Harman aims to expand in Chinese market
China Daily· 2 小時前Driven by an automobile production boom in China, Harman International, a United States-based manufacturer</ ...
Samsung Electronics' operating profit jumps 933% in first quarter, beats expectations
CNBC· 5 日前Samsung, the world's most prolific smartphone maker, is leaning into artificial ...
Huawei’s Richard Yu said to move up as chairman of firm’s consumer business
South China Morning Post· 4 日前Yu, 54, will be replaced as chief executive at Huawei’s consumer business group by He Gang, who ...
Russia ramps up arms production as US boosts support for Ukraine
Reuters· 4 日前Russia's defence minister on Wednesday ordered a hike in weapons production and said ...